Topics
September 2017 | Special Feature
The Eye as a Window for Early Diagnosis of Obstructive Sleep Apnea
Objective measures on OCTA may allow more effective management of this common condition.
Lauren Lombardi; Lotem Nativ; Omar Helmy, MD; and Shlomit Schaal, MD, PhD
June 19, 2026
Lexitas Pharma Services Named Octane Preferred Advisor
Potential Drug Signals Linked to Wet AMD Identified in Integrative Analysis
Foundation Fighting Blindness Receives $1 Million Commitment to Advance Gene-Agnostic IRD Therapies
June 18, 2026
Ocular Therapeutix Aligns with FDA on Planned Axpaxli NDA Submission for Wet AMD
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Supported by Zeiss
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
